Literature DB >> 7537959

Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.

N F van Det1, J van den Born, J T Tamsma, N A Verhagen, L P van den Heuvel, J H Berden, J A Bruijn, M R Daha, F J van der Woude.   

Abstract

Proteoglycans metabolically labelled with [35S]sulphate and [3H]glucosamine or [3H]leucine were isolated from the incubation medium and cell layer of human adult mesangial cells and glomerular visceral epithelial cells using sequential DEAE chromatography purification steps followed by gel-filtration chromatography. The proteoglycan composition of each peak was analysed by treatment with HNO2, chondroitinase ABC or chondroitinase AC followed by chromatography on Sephadex G-50 columns. Heparan sulphate proteoglycan (HSPG) and dermatan sulphate proteoglycan were detected in both the culture medium and cell layer of mesangial cells. Culture medium of glomerular visceral epithelial cells contained HSPG and a second proteoglycan with the properties of a hybrid molecule containing HS and chondroitin sulphate (CS). The cell layer contained HSPG and CSPG. Detailed analysis of the hybrid molecule revealed that it had an apparent molecular mass of 400 kDa. SDS/PAGE of hybrid molecules, after treatment with heparitinase and chondroitinase ABC, revealed a core protein of 80 kDa. Using 1.8% polyacrylamide/0.6% agarose-gel electrophoresis, we deduced that the HS and CS were independently attached to one core protein. Because glomerular-basement-membrane HSPG is thought to be derived from mesangial cells and glomerular visceral epithelial cells and this molecule is involved in several kidney diseases, we investigated its synthesis in more detail. Anti-(rat glomerular-basement-membrane HSPG) monoclonal antibodies (JM403) and anti-(human glomerular-basement-membrane HSPG) polyclonal antibodies (both antibodies known to react with the large basement-membrane HSPG, perlecan) reacted strongly with HSPG obtained from both mesangial cells and glomerular visceral epithelial cells. However, the hybrid molecule did not react with these antibodies, suggesting that the HS side chain and the core protein were different from glomerular-basement-membrane HSPG. To quantify HS we performed an inhibition ELISA using mouse antibodies specific for glomerular-basement-membrane HS glycosaminoglycan side chains. Glomerular visceral epithelial cells produced significantly higher levels of HS (between 197.56 and 269.40 micrograms/72 h per 10(6) cells) than mesangial cells (between 29.8 and 45.5 micrograms/72 h per 10(6) cells) (three different cell lines; n = 3; P < 0.001). HS production by these cells was inhibited by cycloheximide, revealing that it was synthesized de novo. Expression of perlecan mRNA, demonstrated using reverse transcriptase PCR, was different in the two cell types. We conclude that glomerular visceral epithelial cells and mesangial cells have characteristic patterns of proteoglycan production. Glomerular visceral epithelial cells produced a hybrid proteoglycan containing CS and HS independently attached to its core protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537959      PMCID: PMC1136715          DOI: 10.1042/bj3070759

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Glomerular basement membrane as a compressible ultrafilter.

Authors:  G B Robinson; H A Walton
Journal:  Microvasc Res       Date:  1989-07       Impact factor: 3.514

3.  Isolation and characterization of fibronectin-binding proteoglycan carrying both heparan sulfate and dermatan sulfate chains from human placenta.

Authors:  M Isemura; N Sato; Y Yamaguchi; J Aikawa; H Munakata; N Hayashi; Z Yosizawa; T Nakamura; A Kubota; M Arakawa
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

Review 4.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane.

Authors:  L P van den Heuvel; J van den Born; T J van de Velden; J H Veerkamp; L A Monnens; C H Schroder; J H Berden
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.

Authors:  J T Tamsma; J van den Born; J A Bruijn; K J Assmann; J J Weening; J H Berden; J Wieslander; E Schrama; J Hermans; J H Veerkamp
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

7.  Identification of the core proteins in proteoglycans synthesized by vascular endothelial cells.

Authors:  A Lindblom; I Carlstedt; L A Fransson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

8.  Multiple forms of heparan sulfate proteoglycans in the Engelbreth-Holm-Swarm mouse tumor. The occurrence of high density forms bearing both heparan sulfate and chondroitin sulfate side chains.

Authors:  M Kato; Y Koike; Y Ito; S Suzuki; K Kimata
Journal:  J Biol Chem       Date:  1987-05-25       Impact factor: 5.157

9.  Changes in heparan sulfate correlate with increased glomerular permeability.

Authors:  G C Groggel; J Stevenson; P Hovingh; A Linker; W A Border
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

10.  Lymphohaemopoietic antigens of cultured human glomerular epithelial cells.

Authors:  F J van der Woude; A F Michael; E Muller; G K van der Hem; R L Vernier; Y Kim
Journal:  Br J Exp Pathol       Date:  1989-02
View more
  3 in total

1.  Complex patterns of alternative splicing mediate the spatial and temporal distribution of perlecan/UNC-52 in Caenorhabditis elegans.

Authors:  G P Mullen; T M Rogalski; J A Bush; P R Gorji; D G Moerman
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Human immunodeficiency virus downregulates podocyte apoE expression.

Authors:  Shitij Arora; Mohammad Husain; Dileep Kumar; Hitesh Patni; Shresh Pathak; Devi Mehrotra; Vivek Kathi Reddy; Lalit Rajeev Reddy; Divya Salhan; Anju Yadav; Peter W Mathieson; Moin A Saleem; Praveen N Chander; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-24

3.  Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.

Authors:  April L Ellis; Wensheng Pan; Guang Yang; Kim Jones; Christine Chuang; John M Whitelock; Arthur A DeCarlo
Journal:  BMC Biotechnol       Date:  2010-09-09       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.